Compare Rukun Raharja Tbk. (RAJA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rukun Raharja Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Rukun Raharja Tbk. trades at Rp820 (market cap 17.23T, 73.86M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Rukun Raharja Tbk. is far larger — about 165× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RAJA | SCPI | |
|---|---|---|
Market Cap | 17.23T | 104.4B |
Volume | 73.86M | — |
Lot | 738.58K | — |
Turnover | 60.72B | — |
Average Price | 822.17 | — |
Value | 60.72B | — |
Indicative Equilibrium Price | 820 | — |
Indicative Equilibrium Volume | 19.57K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rukun Raharja Tbk.
PT Rukun Raharja (the company) was established by deed No. 290 dated December 24, 1993 were made before Ir. Rusli, S.H., and amended by deed No. 163 dated February 19, 1994 which made Kristianto, S.H., notary in Jakarta.On Jan 2003, the company offered 120.000.000 stock and 84.000.000 warrant through the Surabaya Stock Exchange with par value of Rp 100 and offering price Rp 110.The Company started its commercial operations on Jan 2002 with early main bussines in property.
Read more on RAJA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
